The Nobel Prize awards in Medicine 2018 are based in part on a discovery made in 1987 in the laboratory of Pierre GOLSTEIN, director of research Inserm. It is indeed his team at CIML, Centre d'Immunologie de Marseille-Luminy, that for the first time identified the CTLA-4 protein, now targeted in certain cancer immunotherapy strategies. CIML Headline
Team
